Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Domagrozumab (PF-06252616), an Antimyostatin Monoclonal Antibody, in Healthy Subjects.
Bhattacharya I, Pawlak S, Marraffino S, Christensen J, Sherlock SP, Alvey C, Morris C, Arkin S, Binks M. Bhattacharya I, et al. Among authors: christensen j. Clin Pharmacol Drug Dev. 2018 Jun;7(5):484-497. doi: 10.1002/cpdd.386. Epub 2017 Sep 7. Clin Pharmacol Drug Dev. 2018. PMID: 28881472 Clinical Trial.
Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial.
Wallace DJ, Strand V, Merrill JT, Popa S, Spindler AJ, Eimon A, Petri M, Smolen JS, Wajdula J, Christensen J, Li C, Diehl A, Vincent MS, Beebe J, Healey P, Sridharan S. Wallace DJ, et al. Among authors: christensen j. Ann Rheum Dis. 2017 Mar;76(3):534-542. doi: 10.1136/annrheumdis-2016-209668. Epub 2016 Sep 26. Ann Rheum Dis. 2017. PMID: 27672124 Free PMC article. Clinical Trial.
Evaluating Feasibility of an Exercise Intervention Including Physical Assessment During the First 6 Months of Cancer Treatment in Children and Adolescents in a Randomized Controlled Trial.
Schmidt-Andersen P, Pouplier A, Faigenbaum AD, Beth CK, Olsen CC, Lykkedegn S, Hasle H, Müller K, Larsen HB, Fridh M, Christensen J. Schmidt-Andersen P, et al. Among authors: christensen j. Pediatr Blood Cancer. 2025 Jan 2:e31498. doi: 10.1002/pbc.31498. Online ahead of print. Pediatr Blood Cancer. 2025. PMID: 39745099
Institution of a formal multidisciplinary heart team for high-risk coronary revascularization.
Potluri S, Sawhney R, Dorton C, McCullough K, Moubarak G, Shih E, Christensen J, DiMaio JM, Al-Azizi K, Dib C, Sayfo S, Szerlip M, Thomas S, Levy A, Hutcheson K, Carranza M, Douthit S, Pettijohn T, Ryan W, Mack M. Potluri S, et al. Among authors: christensen j. Proc (Bayl Univ Med Cent). 2024 Nov 22;38(1):28-33. doi: 10.1080/08998280.2024.2426925. eCollection 2025. Proc (Bayl Univ Med Cent). 2024. PMID: 39712420 Free PMC article.
Genomic, transcriptomic, and metabolomic analyses reveal convergent evolution of oxime biosynthesis in Darwin's orchid.
Jiang K, Møller BL, Luo S, Yang Y, Nelson DR, Jakobsen Neilson EH, Christensen JM, Hua K, Hu C, Zeng X, Motawie MS, Wan T, Hu GW, Onjalalaina GE, Wang Y, Gaitán-Espitia JD, Wang Z, Xu XY, He J, Wang L, Li Y, Peng DH, Lan S, Zhang H, Wang QF, Liu ZJ, Huang WC. Jiang K, et al. Among authors: christensen jm. Mol Plant. 2024 Dec 18:S1674-2052(24)00394-0. doi: 10.1016/j.molp.2024.12.010. Online ahead of print. Mol Plant. 2024. PMID: 39702965
4,202 results